Tag: fiscal year 2026
F&P fields questions on mask pipeline, tariff impact
May 27, 2026Liz Beaulieu, Editor
AUCKLAND, New Zealand – Analysts pressed Fisher & Paykel Healthcare executives during a recent earnings call on the company’s lack of new full-face mask launches for obstructive sleep apnea (OSA), even as other product categories continue to gain traction.
Analyst Ben Crozier described the full-face mask category as “a bit of a headwind” for F&P, noting it has been offset by more recent and frequent launches in other categories, including the F&P Solo (nasal), F&P Nova...
Resmed cites momentum, continued progress in Q3
April 30, 2026HME News Staff
SAN DIEGO – Resmed reported revenue increased by 11% to $1.4 billion for the third quarter fiscal year 2026.
Other financial results:
GAAP gross margin up 290 bps to 62.2%; non-GAAP gross margin up 290 bps to 62.8%
GAAP income from operations increased 17%; non-GAAP income from operations up 18%
GAAP diluted earnings per share of $2.74; non-GAAP diluted earnings per share of $2.86
Operating cash...
Cardinal Health raises profit growth for Other segment
April 30, 2026HME News Staff
DUBLIN, Ohio – Cardinal Health’s Other segment saw a 31% increase in revenue in the third quarter of fiscal year 2026 to $1.7 billion, driven by growth across the three operating segments, including at-Home Solutions. The company now expects the segment to see profit growth of 36% to 38% for the year.
Other financial results
Overall revenue increased 11% to $60.9 billion.
Third quarter GAAP operating earnings decreased 30% to $509 million and GAAP diluted earnings per share...
McKesson reports flat revenues for Medical-Surgical segment
February 9, 2026HME News Staff
IRVING, Texas – McKesson has reported $3 billion in revenues for the third quarter of fiscal year 2026 for its Medical-Surgical Solutions segment, a 1% increase, driven by higher volumes of specialty pharmaceuticals.
For the segment, operating profit was $265 million, and adjusted segment operating profit was $265 million, a 10% decrease, driven by lower volumes across physician office settings and lower incidence of illness for the season.
McKesson reported $106.2...
Cardinal’s at-Home Solutions helps to push double-digit growth
February 5, 2026HME News Staff
DUBLIN, Ohio – Cardinal Health has reported that revenue for its Other segment, which includes at-Home Solutions, increased 34% to $1.7 billion for its second quarter fiscal year 2026. Profit for the Other segment increased 52% to $179 million.
Overall, Cardinal Health reported revenue increased 19% to $65.6 billion.
“Our strong second-quarter performance reflects at least double-digit segment profit growth across all five of our operating...
Resmed reports 11% increase in revenues for Q2
January 29, 2026HME News Staff
SAN DIEGO – Resmed reported revenue increased 11% to $1.4 billion for its second quarter of fiscal year 2026.
Other financial results:
Gross margin up 320 bps to 61.8%; non-GAAP gross margin up 310 bps to 62.3%.
Income from operations increased 18%; non-GAAP income from operations up 19%.
Diluted earnings per share of $2.68; non-GAAP diluted earnings per share of $2.81.
Operating cash flow of $340 million.
“Our...
Cardinal Health updates guidance
January 20, 2026HME News Staff
DUBLIN, Ohio – Cardinal Health has updated its financial outlook for fiscal year 2026 non-GAAP diluted earnings per share (EPS) to at least $10 from its prior guidance range of $9.65 to $9.85. This increased outlook is driven by strong performance and execution across the company’s five operating segments, the company says. "Our team's execution against our strategic growth plan continues to deliver meaningful results, and as a demonstration...
McKesson sees flat growth in Medical-Surgical segment
November 10, 2025HME News Staff
IRVING, Texas – McKesson reported revenues of $2.9 billion for its Medical-Surgical Segment for the second quarter of fiscal year 2026, flat to the same period the prior year. Revenues were driven by higher volumes of specialty pharmaceuticals, offset by lower contributions from illness season products and testing. Operating profit for the segment was $220 million and adjusted operating profit was $249 million, a 2% increase, driven by operational efficiencies...
Resmed says it’s off to a strong start with 9% increase in revenue
October 30, 2025HME News Staff
SAN DIEGO – Resmed reported revenue of $1.9 billion for the first quarter of fiscal year 2026, a 9% increase compared to the same period in 2025.
“Our fiscal year 2026 is off to a strong start, with first-quarter performance reflecting continued progress toward our mission of helping people sleep better, breathe better and live longer and healthier, with care provided in their own home,” said Resmed’s Chairman and CEO Mick Farrell.
Other financial results:
Gross...